Pilot Pharmacokinetic and Dosimetric Studies of18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3Integrin Levels-Reference-Cited by-同舟云学术

Pilot Pharmacokinetic and Dosimetric Studies of18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3Integrin Levels

Published:2011-07 Issue:1 Volume:260 Page:182-191
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Mittra Erik S.,Goris Michael L.,Iagaru Andrei H.,Kardan Arash,Burton Lindee,Berganos Rhona,Chang Edwin,Liu Shuanglong,Shen Bin,Chin Frederick T.,Chen Xiaoyuan,Gambhir Sanjiv S.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.11101139

Reference38 articles.

1. Role of angiogenesis in tumor growth and metastasis

2. Vascular-targeting therapies for treatment of malignant disease

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics;International Journal of Molecular Sciences;2024-08-05

2. Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [⁶⁸Ga]Ga-DOTA-FGFR1-Peptide;Cancer Biotherapy and Radiopharmaceuticals;2024-07-18

3. Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-20

4. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody;European Journal of Nuclear Medicine and Molecular Imaging;2024-01-13

5. Radionuclide-based theranostics — a promising strategy for lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-03-16